AstraZeneca is one of the world's leading pharmaceutical companies. Backed by a strong research base and extensive manufacturing and commercial skills, the company provides a powerful range of products for six important areas of healthcare - gastrointestinal, cardiovascular, cancer, respiratory, neurosciences and infection. With its headquarters based in UK, AstraZeneca has its R&D facilities basedin Sweden, USA, Japan & India.
The company sells its products in over 100 countries, manufactures in 27 and has major research centres in 11. It employs over 65,000 people worldwide and values the diversity of skills and abilities that they bring to the business. R&D is based in Sweden, the UK, the USA, Canada, France, India & Japan. The company is recognised as having one of the best development pipelines in the industry and spends over $14 million each working day to maintain a flow of new medicines designed to meet patients’ needs. AstraZeneca invests over US$ 3.4 billion a year on R&D activities including Discovery Research. The company worldwide sales in 2005 totalled $24 billion.